Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / ADS
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
10.3M
-
Shares change
-
+7.18M
-
Total reported value, excl. options
-
$247M
-
Value change
-
+$171M
-
Number of buys
-
18
-
Price
-
$23.89
Significant Holders of Silence Therapeutics plc - ADS (SLN) as of Q4 2021
21 filings reported holding SLN - Silence Therapeutics plc - ADS as of Q4 2021.
Silence Therapeutics plc - ADS (SLN) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3M shares
.
Largest 10 shareholders include Lombard Odier Asset Management (USA) Corp (3.47M shares), Deep Track Capital, LP (951K shares), FRAZIER MANAGEMENT LLC (886K shares), GOLDMAN SACHS GROUP INC (760K shares), Consonance Capital Management LP (758K shares), BVF INC/IL (667K shares), AXA S.A. (662K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (550K shares), GREAT POINT PARTNERS LLC (444K shares), and CANTOR FITZGERALD, L. P. (255K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.